Glenmede Trust CO Na United Therapeutics Corp Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in United Therapeutics Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 68,605 shares of UTHR stock, worth $26.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

68,605

Previous 64,460 6.43%

Holding current value

$26.5 Million

Previous $20.5 Million 19.73%

% of portfolio

0.12%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $1.29 Million - $1.51 Million	4,145 Added 6.43%	68,605 $24.6 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $1.98 Million - $2.77 Million	-8,674 Reduced 11.86%	64,460 $20.5 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $1.14 Million - $1.35 Million	5,428 Added 8.02%	73,134 $16.8 Million
Q4 2023 Feb 13, 2024	SELL	$214.88 - $256.94 $84,232 - $100,720	-392 Reduced 0.58%	67,706 $14.9 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $12.9 Million - $15.1 Million	60,854 Added 840.06%	68,098 $15.4 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $50,052 - $64,899	235 Added 3.35%	7,244 $1.62 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $5,560 - $7,571	-27 Reduced 0.38%	7,009 $1.95 Million
Q3 2022 Nov 16, 2022	BUY	$203.3 - $244.17 $1.43 Million - $1.72 Million	7,036 New	7,036 $1.47 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $2,225 - $3,019	-24 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$78.31 - $95.34 $1,096 - $1,334	-14 Reduced 36.84%	24 $2,000
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $13,398 - $15,392	-179 Reduced 82.49%	38 $3,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $3.83 Million - $6.09 Million	-50,396 Reduced 99.57%	217 $16,000
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $39,109 - $46,296	-365 Reduced 0.72%	50,613 $5.94 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $1.96 Million - $2.49 Million	19,321 Added 61.03%	50,978 $5.55 Million
Q3 2018 Nov 15, 2018	SELL	$113.81 - $129.46 $2.36 Million - $2.69 Million	-20,742 Reduced 39.58%	31,657 $4.05 Million
Q2 2018 Aug 15, 2018	SELL	$101.14 - $118.31 $2.36 Million - $2.76 Million	-23,338 Reduced 30.81%	52,399 $5.93 Million
Q4 2017 Feb 15, 2018	SELL	$118.58 - $151.28 $216,527 - $276,237	-1,826 Reduced 2.35%	75,737 $11.2 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $8.89 Million - $10.6 Million	77,563	77,563 $0

Others Institutions Holding UTHR

# of Institutions

657

Shares Held

42.8M

Call Options Held

153K

Put Options Held

278K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na United Therapeutics Corp Transaction History